Quiz: Radionuclide Therapy A multiple-choice quiz consists of: 10 QuestionsQuestions are selected randomly from a collection of 17 questions. More Questions You will get deferent questions every time you take the quiz. Correct AnswersThere could be more than one correct answer, select all that apply.Skip QuestionsYou are allowed to scroll backward and forward before submitting your answers.10 MinutesThe quiz has a time limit. Time's up You can still submit your answers after the allowed period of time has ended . When ready, click Next to start the quiz. Name (Required) Email (Optional) Twitter (Optional) 1. Treatment of hyperthyroidism with antithyroid medications must be given for 6 months to 2 years, in order to be effective. The two main antithyroid drugs are: Metronidazole and Propranolol Methimazole and Propylthiouracil Metronidazole and Propylthiouracil Methimazole and Propranolol None 2. The hematologic toxicity of Y-90 Zevalin therapy is common. All of the following can be a sign of hematologic toxicity EXCEPT: Arrhythmia Anemia Fever Bruising None 3. Which of the following radioisotopes approved used in the treatment of bone metastases has a significant gamma emission and can be used both for imaging and therapy? Sm-153 Sr-89 Ra-223 P-32 None 4. Which of the following property of radiation is principally used in the treatment of tumors? Fluorescent effect Chemical effect Biologic effect Photographic effect None 5. Which of the following time is advised for patients treated with 1-131 to delay conception after treatment? 6 months 4 months 1 month 2 months None 6. Iodine-131 is considered to be the treatment of choice in many patients with Graves’ disease. The most common side effect of radioactive iodine (RAI) treatment is: Thyroiditis Thyroid carcinoma Hyperthyroidism Hypothyroidism None 7. A lone “cold” nodule in an otherwise normal thyroid gland warrants: Fine needle aspiration biopsy. Radiation therapy. Surgical removal. Chemotherapy. None 8. All breastfeeding women undergoing I-131 therapy should be asked to stop breastfeeding and therapy is delayed until lactation ceases. According to the Society of Nuclear Medicine (SNM) procedure guidelines, the patient may resume breastfeeding: After 3 months. After 6 months. With the birth of another child. Never. None 9. The general pretreatment requirements for adult qualifying for therapy with I-131 metaiodobenzylguanidine (MIBG) include the following EXCEPT: A diagnostic MIBG scan or previous posttreatment I-131 MIBG scan Performing pulmonary function tests Reviewing potential interfering medications Blocking thyroid uptake of free radioiodine None 10. Samarium-153 (Quadramet) is a therapeutic radiopharmaceutical used to treat: Dyspnea in lung Ca Polycythemia vera Pain in bony metastases Medullary thyroid carcinoma None 1 out of 10 Time's upTime is Up! By Nasser AlMutairi|2021-09-20T13:15:38+03:00April 26th, 2021|Radionuclide Therapy| شارك هذه الصفحة FacebookXLinkedInWhatsAppPinterestEmail About the Author: Nasser AlMutairi Senior Nuclear Medicine Specialist at Hafar Al-Batin Central Hospital, Founder of NuclearMed Website. One Comment Muawia Ibrahim Elgak January 10, 2025 at 6:37 pm - Reply Thank you for your questions Leave A Comment Cancel replyComment Notify me of follow-up comments by email. Notify me of new posts by email. Δ
Thank you for your questions